George Demetri - Dissemin

All papers authored by George Demetri

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Data from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Table S1 from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Supplementary Figures 1-6 from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Table S4 from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Table S3 from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Table S6 from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Table S5 from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri

, Scott A. Armstrong, Ewa Sicinska, Suzanne George

Table S2 from Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Upload

George D. Demetri

, Jason J. Luke, Antoine Hollebecque, John D. Powderly, Alexander I. Spira, Vivek Subbiah, Louie Naumovski, Chris Chen, Hua Fang, Dominic W. Lai, Huibin Yue, Akshanth R. Polepally, James W. Purcell, Randy Robinson, Padmanee Sharma and 3 other authors

Supplementary Table S2 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

Upload

George D. Demetri

Supplementary Table S1 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

Upload

George D. Demetri

, Filippo De Braud, Alexander Drilon, Salvatore Siena, Manish R. Patel, Byoung Chul Cho, Stephen V. Liu, Myung-Ju Ahn, Chao-Hua Chiu, Jessica J. Lin, Koichi Goto, Jeeyun Lee, Lyudmila Bazhenova, Thomas John, Marwan Fakih and 8 other authors

Data from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors

Upload

George D. Demetri

Supplementary Data from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors

Upload

George D. Demetri

Supplementary Figure S2 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

Upload

George D. Demetri

Supplementary Figure S1 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

Upload

George D. Demetri

Data from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

Upload

George D. Demetri

Supplementary Table S3 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

Upload

George D. Demetri

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors

Upload

George D. Demetri

Supplementary Figure S3 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 George D. Demetri

, Filippo De Braud, Alexander Drilon

, Salvatore Siena

, Manish R. Patel

, Byoung Chul Cho

, Stephen V. Liu

, Myung-Ju Ahn

, Chao-Hua Chiu, Jessica J. Lin

, Koichi Goto

, Jeeyun Lee, Lyudmila Bazhenova

, Thomas John

, Marwan Fakih and 8 other authors

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors

Upload

2021 Bhakti Arondekar

, Mei Sheng Duh, Rachel H. Bhak

, Maral DerSarkissian, Lynn Huynh, Kelsey Wang, John Wojciehowski, Melody Wu, Bryon Wornson, Alexander Niyazov, George D. Demetri

Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by George Demetri